amgen inc (AMGN:NASDAQ GS)

Executive Profile*

Background*

Dr. Fabrizio J. Bonanni served as an Executive Vice President of Amgen Inc. Dr. Bonanni served as an Executive Vice President of Operations of Amgen Inc., from August 1, 2007 to August 13, 2012. Dr. Bonanni oversees Amgen's global commercial production activities as well as site expansion and facilities management. He serves as Secretary at Biotechnology Industry Organization (BIO). He served as Senior Vice President, Quality and Compliance of Amgen Inc. since April ... 1999, where he oversaw Quality Control, Quality Assurance, Regulatory Compliance and Environmental Health and Safety. He served as Senior Vice President of Manufacturing of Amgen Inc. Previously, Dr. Bonanni held various management positions at Baxter International from 1974 to 1999, including Vice President, Regulatory and Clinical Affairs and the Corporate Vice President. From December 1997 to April 1999, Dr. Bonanni served as Corporate Vice President for Regulatory, Clinical Affairs of Baxter and from November 1994 to December 1997, as Corporate Vice President, Quality System. Beginning in 1974, he held a variety of quality, regulatory and manufacturing positions at Baxter in Europe and in the United States. Dr. Bonanni serves on the Board of Trustees of the California Science Center. He serves as a Director and Member of Health Section Governing Board at Biotechnology Industry Organization (BIO). He serves on the Board of Trustees of Museum of Contemporary Art in Los Angeles. He also serves as a Trustee of the Science Technology and Research Trust of Puerto Rico. He served as a Director of Aastrom Biosciences Inc. since September 2000. He is a State Certified Chemist and member of the Ordine dei Chimici of Tuscany, Italy. Dr. Bonanni is an Alumnus of the Institute for International Management at Northwestern University, J.L. Kellogg Graduate School of Management, and of the Executive Program in Manufacturing at Harvard University, Graduate School of Business Administration. Dr. Bonanni studied Doctorate in Chemistry (magna cum laude and with mention of honor) from the University of Florence, Italy and has done postdoctoral work in physiological chemistry at the Massachusetts Institute of Technology. He is fluent in French and English, in addition to his native Florentine Italian.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
AMGN:US	$105.62 USD	+1.09

COMPETITOR COMPENSATION